BROMFENAC 0.09%w/v IP + BENZALKONIUM CHLORIDE 0.005%v/v IP

An ocular anti-inflammatory drug for the treatment of postoperative inflammation and reduction of ocular pain. (Eric D Donnenfeld, 2007) A potent and long-acting compared to indomethacin, possesses anti-inflammatory, antipyretic, and prostaglandin synthetase-inhibiting properties. (Kaori Yanai, 2013) Effectively and rapidly clears ocular inflammation and reduces ocular pain after cataract extraction. (Eric D Donnenfeld, 2007) A safe and effective eye solution for reducing and treating ocular inflammation and pain associated with cataract surgery. (Bonnie A Henderson, 2011) An ophthalmic solution that is effective in treating the pain associated with infectious keratitis. (Barry A Schechter, 2010) A safer agent than other non-steroidal anti-inflammatory drugs (NSAIDs) drops with regards to ocular surface complications. (Nimmy Raj, 2022) More potent than indomethacin in suppressing acute and chronic inflammation. (L F Sancilio, 1987) A valuable tool in the ophthalmic NSAID armamentarium. (Rajesh K Rajpal, 2014) Shows a more rapid onset of anti-inflammatory activity than diclofenac in patients who underwent cataract surgery. (Hyung Cho, 2009) The most effective anti-inflammatory agent for attenuating the elevated levels of inflammatory cytokines in the aqueous humour of pseudophakic eyes. (Takehiro Matsumura, 2021)